Edgewise Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Edgewise Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2021 to Q3 2024.
  • Edgewise Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 93.8M shares, a 47.8% increase year-over-year.
  • Edgewise Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 63.7M shares, a 18.9% increase from 2022.
  • Edgewise Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 53.6M shares, a 42.8% increase from 2021.
  • Edgewise Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 37.5M shares, a 4978% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 93.8M +30.4M +47.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 93.5M +30.1M +47.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 87.6M +24.3M +38.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 63.7M +10.1M +18.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 63.5M +11.6M +22.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 63.4M +13.8M +27.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 63.3M +13.7M +27.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 53.6M +16.1M +42.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 51.8M +2.58M +5.24% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 49.6M +364K +0.74% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 49.5M +48M +3076% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 37.5M Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 49.3M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 49.3M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 1.56M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.